SightfileU.S. market data from official filings
Companies › ACIU
AC IMMUNE SA (ACIU)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001651625 · EDGAR filings · Updated 2026-06-30
AC IMMUNE SA (ACIU) has reported institutional ownership of 24.7%, with 46 institutional managers holding positions valued at $69.0M per the latest 13F reporting period.
Institutional ownership
24.7%
Institutional managers
46
Reported 13F value
$69.0M
Latest updates
- 2026-06-30 — Foreign issuer report (6-K) filed
- 2026-06-15 — Insider transaction reported (Form 4)
- 2026-06-15 — Insider transaction reported (Form 4)
- 2026-06-15 — Insider transaction reported (Form 4)
- 2026-06-15 — Insider transaction reported (Form 4)
- 2026-06-15 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, AC IMMUNE SA has 46 institutional holders and institutional ownership of 24.7%.
Insider activity
Insiders reported 0 transactions (0 buys, 0 sells) across 7 reporting insiders, with a net reported value of $0.
Related companies
SNDL INC (SNDL) · IMMUNIC (IMUX) · SAGIMET BIOSCIENCES INC (SGMT) · LEONABIO INC (LONA) · Unicycive Therapeutics Inc (UNCY) · LIFEMD (LFMD)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-30.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-30.